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Abstract The phospholipid composition of lipoproteins is
determined by the specificity of hepatic phospholipid biosyn-
thesis. Plasma phospholipid 20:4n-6 and 22:6n-3 concentra-
tions are higher in women than in men. We used this sex
difference in a lipidomics analysis of the impact of endocrine
factors on the phospholipid class and molecular species compo-
sition of fasting plasma from young men and women. Diester
species predominated in all lipid classes measured. 20/54 Phos-
phatidylcholine (PtdCho) species were alkyl ester, 15/48 phos-
phatidylethanolamine (PtdEtn) species were alkyl ester, and
12/48 PtdEtn species were alkenyl ester. There were no signifi-
cant differences between sexes in the proportions of alkyl
PtdCho species. The proportion of alkyl ester PtdEtn species
was greater in women than men, while the proportion of
alkenyl ester PtdEtn species was greater in men than women.
None of the phosphatidylinositol (PtdIns) or phosphatidylserine
(PtdSer) molecular species contained ether-linked fatty acids.
The proportion of PtdCho16:0_22:6, and the proportions of
PtdEtn O-16:0_20:4 and PtdEtn O-18:2_20:4 were greater in
women than men. There were no sex differences in PtdIns and
PtdSer molecular species compositions. These findings show
that plasma phospholipids can be modified by sex. Such differ-
ences in lipoprotein phospholipid composition could contribute
to sexual dimorphism in patterns of health and disease.
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Introduction
The molecular species composition of phospholipids differs
between tissues and phospholipid classes (Inoue
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et al., 2017) and is regulated by biochemical and genetic
processes (Zhang and Rock, 2008). The combination of
fatty acids bound at the sn-1 and sn-2 positions, at least in
part, determines the biophysical properties of cell mem-
branes which influence the activities of integral membrane
proteins (Ces, 2006; Dymond et al., 2013) and provide sub-
strates for signaling processes (Heung and Postle, 1995a,
b). Thus, factors that confer membrane phospholipid
homeostasis are important for maintaining cell function
(Calder, 2008). Fasting plasma phospholipid molecular
species composition primarily reflects that of the liver and
hepatic phospholipid synthesis (Burdge et al., 1994; Chalil
et al., 2018; Pynn et al., 2011). Therefore, plasma phospho-
lipid composition can be a proxy for hepatic phospholipid
composition and can provide insights into phospholipid
metabolism in the liver.
Synthesis of phosphatidylcholine (PtdCho), which is the
predominant component of the lipoprotein phospholipid
monolayer, is required for the formation and secretion of
very low density lipoproteins (VLDL) (Yao and
Vance, 1988). Inhibition of PtdCho synthesis can alter the
phospholipid composition and structure of VLDL particles
(Fast and Vance, 1995). Hepatic PtdCho and phosphatidyl-
ethanolamine (PtdEtn) are synthesized via the Kennedy
pathway from CDP-choline and CDP-ethanolamine,
respectively (Gibellini and Smith, 2010; Kanoh and
Ohno, 1975; Weiss et al., 1958). The composition of newly
synthesized phospholipids reflects that of the metabolically
and compositionally distinct diacylglycerol (DAG) sub-
strate pools (Burdge et al., 1994; Rustow et al., 1985;
Rustow and Kunze, 1985). Approximately 30% of hepatic
PtdCho synthesis occurs by the PtdEtn N-methylation path-
way (Sundler and Akesson, 1975; Vance et al., 1997),
which yields mainly polyunsaturated fatty acid (PUFA)-
containing PtdCho species (Burdge et al., 1994; Chalil
et al., 2018). The minor plasma phospholipids, namely pho-
sphatidylinositol (PtdIns), and phosphatidylserine (PtdSer),
are synthesized by PtdIns synthase via CDP-DAG
(Blunsom and Cockcroft, 2020) and by base exchange with
PtdCho (PtdSer synthase I) or with PtdEtn (PtdSer synthase
II) (Leventis and Grinstein, 2010), respectively. The roles
of PtdIns and PtdSer in lipoprotein function are not known.
Newly synthesized phospholipids can undergo acyl remo-
deling processes via the Lands cycle (Lands, 1960) to gen-
erate the molecular species composition of the mature
phospholipid pool. This involves phospholipase A2 (PLA2)
or PLA1, and lyso phospholipid acyltransferase (LPAT)
activities (Schmid et al., 1991; Wang and Tontonoz, 2019).
Specificity of acyl remodeling, and hence the composition
of the final phospholipid pool, is conferred by LPAT sub-
strate selectivity (Wang and Tontonoz, 2019). For example,
in rat and guinea pig liver, newly synthesized PtdCho
undergoes acyl exchange at the sn-1 position, which results
in partial conversion of sn-1 16:0 to sn-2 18:0 species
(Burdge et al., 1993, 1994).
It is well established that phospholipid biosynthesis and
membrane composition are under genetic and biochemical
control (Sugimoto et al., 2008). However, the molecular
species composition of hepatic and plasma phospholipids
appears to also be under endocrine control. In pregnant
women, increasing gestational age is accompanied by
changes in plasma PtdCho 18:1n-9, 18:2n-6, 20:4n-6 and
22:6n-3 concentrations (Al et al., 2000; Meyer et al., 2016),
specifically in sn-1 16:0 or sn-1 18:1n-9 PtdCho molecular
species (Postle et al., 1995). Similarly, pregnancy in rats
involves a differential increase in hepatic and plasma
PtdCho16:0/22:6 and 16:0/20:4 concentrations compared
to 18:0/22:6 and 18:0/20:4 concentrations (Burdge
et al., 1994; Chalil et al., 2018; Childs et al., 2012), which
reflects the increased sn-1 16:0 content of the DAG sub-
strate pools destined for PtdCho and PtdEtn synthesis, and
reduced flux through the acyl remodeling pathway.
Together adaptations result in enrichment sn-1 16:0 PtdCho
and PtdEtn molecular species without a change in the spec-
ificity of the Lands cycle (Burdge et al., 1994). Administra-
tion of sex hormones to gonadectomized rats induced
reciprocal changes in the PUFA content of liver phospho-
lipids (Eden et al., 1987). One implication of these findings
is that regulation of hepatic and plasma phospholipid com-
positions may be important for sex-related tissue and lipo-
protein functions.
The proportions of 20:4n-6 and 22:6n-3 are typically
20% higher in total fasting plasma lipids and in phospho-
lipids from women compared to men (Lohner
et al., 2013). This sex difference is independent of die-
tary fatty acid intakes (Bakewell et al., 2006), and may
be explained, at least in part, by greater capacity for
PUFA biosynthesis in young women than in men
(Burdge et al., 2002; Burdge and Wootton, 2002). Here,
we used the differences in the proportions and/or concen-
trations of PUFA between men and women (Lohner
et al., 2013) as a model to investigate the specificity of
sex-related differences in plasma phospholipid composi-
tion. We analyzed the PtdCho, PtdEtn, PtdIns, and
PtdSer molecular species compositions of plasma col-
lected from fasting healthy men and women.
Materials and Methods
Ethics Statement
The study was reviewed by the South Central—Hampshire
B Research Ethics Committee (REC reference 15/SC/0627)
who approved the study and participants gave written
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informed consent. The study is registered at ClinicalTrials.
gov (Identifier: NCT03477045).
Participants and Sample Collection
Blood samples were collected at baseline from a postpran-
dial lipid metabolism study that has been reported in detail
previously (West et al., 2019). Briefly, participants were
10 healthy men aged 25  1 year and 10 healthy women
aged 25  1 year, both with body-mass-index of
24  1 kg/m2. Participants had blood pressure, and fasting
total triacylglycerol, cholesterol, and glucose concentra-
tions within normal ranges (West et al., 2019). The habitual
diets of the participants were not matched or modified for
the purpose of the study. Volunteers were excluded if they
consumed oily fish more than once per week, took fish oil
or other dietary supplements and/or smoked tobacco.
Venous blood was collected at approximately 8:00 AM
after fasting overnight for approximately 12 h into tubes
containing lithium heparin anticoagulant. Cells were
removed from blood by centrifugation at 4C (West
et al., 2016) and the plasma then stored at −80C.
Analysis of Plasma Phospholipid Molecular Species
Compositions
The methods for lipid extraction and analysis by liquid
chromatography/mass spectrometry have been described
previously (West et al., 2020). Briefly, total lipids were
extracted from plasma (200 μL) with methyl-tert-butyl-
ether (MTBE) (Matyash et al., 2008). The organic phase
was dried under a stream of nitrogen, dissolved in chloro-
form/methanol (9:1, v/v) and stored at −20C in a nitrogen
atmosphere.
Phospholipid molecular species compositions were ana-
lyzed by high resolution/accurate mass (HR/AM)
lipidomics using a Vanquish—Q Exactive Plus UPLC-MS/
MS system (Thermo Fisher Scientific, Newport, Gwent,
UK) as described (West et al., 2020). Briefly, plasma total
lipids were resuspended in 500 μL chloroform: methanol
(1:1, v/v) and along with the internal standard
PtdCho24:1/24:1 (0.857 μM). The autosampler tray was
maintained at 10 C and 20 μL of each sample was injected
into the ultra-performance liquid chromatography (UPLC)/
MS system. Chromatographic separation was achieved
using an Accucore C18 (2.1 μm × 150 mm, 2.6 mm) col-
umn (Thermo Fisher Scientific) at 35C with a flow rate of
400 μL/min. An elution gradient was applied to column of
mobile phase A (10 mM ammonium formate in 50% aceto-
nitrile +0.1% (v/v) formic acid) and B (2 mM ammonium
formate in acetonitrile: propan-2-ol: water (10:88:2 v/v/v)
+ 0.02% (v/v) formic acid) over 28 min; starting at 35%
(v/v) B, then 60% B at 4 min, 85% B at 12 min, and 100%
(v/v) B at 21 min which was held for 3 min before equili-
brating for 4 min at 35% B prior to the next run. The elu-
tion system was based on Bird et al. (2011), but was
modified such that ammonium formate concentration was
varied in order to optimize the ionization conditions for the
different lipid classes (Constantinou et al., 2020).
The Thermo Q Exactive HESI II sweep plate set in posi-
tion C. Conditions were adjusted for separate positive and
negative runs; replicate runs of samples in a single polarity
increased the number of identifications. LC/MS at 140K
full scan data HCD MS2 experiments (35K resolution)
were performed in positive and negative ion modes. Full
Scan was operated at 140,000 resolution across m/z
150–1200, with Top 15 selection MS/MS at 35,000 resolu-
tion. The stepped collision energy used was 25, 30, 40, and
the dynamic exclusion set to 8s. The sheath gas set to
60 (arbitrary units), auxillary gas 20, sweep gas 1, spray
voltage 3 KV in positive ion mode and 3.2KV negative ion
mode, S-lens at 50 for +ve ion and 60 in -ve ion, capillary
temperature 320 C and aux gas heater set to 370C. Auto-
matic gain targets of 16 (full scan MS) and 15 (MS/MS)
were used. This protocol was optimized to fragment as
many of the detected peaks as possible to allow them to be
identified by comparison to MS/MS libraries. The samples
were run on the instrument in a random order and analyzed
blind using a number coding system. Blanks were run
every four samples to check for carry over and background
effects. The first sample of the batch was rerun at the end
of the batch to check for any difference in performance.
LipidSearch 4.2 experimental workflow (Thermo Fisher
Scientific) was used for lipid characterization and putative
lipid species were identified separately from positive or
negative ion adducts. The data for each replicate were
aligned within a chromatographic retention time window
by combining the positive and negative ion annotations and
merging these into a single annotation. The MS/MS frag-
mentation spectrum was used to identify the class and fatty
chain composition of the lipid species. Experimental
MS/MS spectra were searched against all lipid classes in
the LipidSearch database using a precursor mass tolerance
of 5 ppm and a product mass tolerance of 8 ppm, and the
quality of the annotation was graded A-D by the software.
Only those graded A or B were used in this analysis. In
grade A, all fatty acyl chains and the class were identified;
in grade B, some fatty acyl chains and the class were identi-
fied. Final assignment was based on UPLC separation. Any
isomers that could not be adequately separated based on
retention time were then subject to additional fragmentation
analysis of the sodium adducts in positive ionization mode
and of the deprotonated species in negative ionization
mode (Huynh et al., 2019).
Peak areas were normalized to the internal standard;
peak areas corresponding to individual phospholipid
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molecular species were expressed as a proportion of the
total species in each lipid class. Raw lipid molecular spe-
cies composition data are deposited at EMBL-EBI Meta-
boLights database (http://www.ebi.ac.uk/metabolights;
Identifier: MTBLS1348) (Haug et al., 2013).
Putative assignment of some fatty acids to sn-1 and sn-2
positions was based on previous analyses of human plasma
phospholipid molecular species (Heung and Postle, 1995b;
Postle et al., 1995; Pynn et al., 2011; West et al., 2020).
However, since the positions of fatty acids were not deter-
mined for all the phospholipid molecular species reported
here, combinations of fatty acids are separated by an under-
score (Murphy, 2018) and do not indicate sn positions.
Lysophospholipids and phosphatidic acid were excluded
from the analyses because they arise as a result of lipase
actions in plasma or as a consequence of sample degrada-
tion, rather than being the product of hepatic synthesis.
Phosphatidic acid was not detected in these samples.
The samples were analyzed blind using a number code
system and in a random order. Blanks were run every four
samples to check for carry over and background effects.
The first sample of the batch was rerun at the end of the
batch to check for any difference in the technical perfor-
mance of the instrument and sample stability in the auto-
sampler. The internal standard, PtdCho 24:1/24:1, was used
to correct for instrument analytical variation.
Statistical Analysis
Molecular species that individually contributed less than
0.01% of total molecular species in each class were
excluded from analysis for differences between sexes.
Analysis of residuals by the Shapiro-Wilks test showed that
all data approximated a normal distribution and hence are
expressed as mean  standard error of the mean (SEM).
Comparisons between men and women were by Student’s
unpaired t-test with adjustment for multiple testing using
the Holm-Šídák method. Statistical significance after
adjustment was assumed at p < 0.05.
Results
Effect of Sex on the Proportions of PtdCho Molecular
Species in Plasma
Thirty-four diester PtdCho molecular species and 20 alkyl-
ester PtdCho molecular species were identified consistently
in plasma from men and women (Tables 1 and 2). The
molecular species profile of plasma PtdCho for all partici-
pants is shown in Fig. 1. sn-1,2 ester-linked PtdCho species
accounted for greater than 95% of all PtdCho molecular
species in men and women (Table 1). The most abundant
species, namely, PtdCho16:0_18:2, PtdCho16:0_18:1, and
PtdCho18:0_18:2 together accounted for 49.3  1.4%
and 47.7  1.2% of total PtdCho molecular species in men
and women, respectively (Table 1). Eighteen diester
PtdCho species in women and 17 diester PtdCho species in
men each contributed less than 0.5% each of the total
PtdCho species, and combined accounted for less than 2%
of total PtdCho species in both sexes (Table 1). Compari-
sons between men and women showed that the proportion
of PtdCho16:0_22:6 was significantly greater (64.4%) in
women than in men (Table 1). Linear regression analysis
showed that differences in sex accounted for 41.9%
(adjusted r2 = 0.419; p = 0.001) of the variation in the pro-
portion of PtdCho16:0_22:6. The proportions of other
PtdCho molecular species did not differ significantly
between men and women.
Alkyl-ester PtdCho species each accounted for less than
4% of total PtdCho molecular species (Table 2). PtdCho O-
18:1_20:4, PtdCho O-16:0_20:4, and PtdCho O-16:1_20:4
were the most abundant alkyl-ester PtdCho species in men
and women, and accounted for less than 1.5% of total
PtdCho molecular species in both sexes. There were no sig-
nificant differences in the proportions of alkyl-ester PtdCho
species between men and women (Table 2).
Effect of Sex on the Proportions of PtdEtn Molecular
Species in Plasma
Plasma from men and women contained 15 diester PtdEtn
molecular species (Table 3), 21 alkyl-ester PtdEtn molecular
species, and 12 alkenyl-ester PtdEtn molecular species
(Table 4). The molecular species profile of plasma PtdEtn for
all participants is shown in Fig. 2. The proportion of total
diester PtdEtn molecular species did not differ significantly
between sexes, while the proportion of total alkyl-ester species
was significantly greater in women than in men. The propor-
tion of total alkenyl-ester molecular species was significantly
greater in men than in women (Table 4).
PtdEtn18:0_20:4, PtdEtn18:0_18:1, and PtdEtn16:0_22:6
together accounted for more than 9.5% of total PtdEtn molecu-
lar species in men and women, which did not differ between
sexes (Table 3). There were no significant differences between
men and women in the proportions of individual diester
PtdEtn molecular species (Table 3). The three most abundant
alkyl ester PtdEtn molecular species were PtdEtn O-
18:1_20:4, PtdEtn O-18:2 _20:4, and PtdEtn O-16: _20:4
which combined accounted for 13.2  1.5% of total PtdEtn
molecular species in men and 18.6  1.1% of total PtdEtn
molecular species in women, which did not differ significantly
between sexes (Table 4). The three most abundant alkenyl-
ester PtdEtn molecular species were PtdEtn P-18:1_20:4,
PtdEtn P-16:0 _20:4, and PtdEtn P-18:0_20:4 in both sexes
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(Table 3). Together these species accounted for
28.1  2.5% of total PtdEtn molecular species in men
and 24.5  0.9% of total molecular species in women,
which did not differ significantly between sexes
(Table 4). The proportion of PtdEtn O-16:1_20:4 and
PtdEtn O-18:2_20:4 were significantly greater in
women (69.9% and 36.7%, respectively) than in men.
Sex accounted for 41.8% of the variation in the propor-
tion of PtdEtn O-16:1 _20:4 (adjusted r2 = 0.418;
p = 0.002) and 25.4% of the variation in the proportion
of PtdEtn O-18:2_20:4 (adjusted r2 = 0.0.254;
p = 0.014). There were no significant differences
between sexes in the proportions of other alkenyl ester
PtdEtn species (Table 4).
Effect of Sex on the Proportions of PtdSer and PtdIns
Molecular Species in Plasma
Three PtdSer molecular species were identified in plasma
from both sexes; PtdSer18:0_18:1, PtdSer18:0_20:4, and
Table 1 Plasma phosphatidylcholine sn-1,2 ester linked molecular species composition in men and women
Proportion of total PtdCho molecular species (%) t-Test
Molecular species Men Women p-value Adjusted p-value
PtdCho14:0_18:2 0.01  0.01 0.01  0.01 0.184 >0.999
PtdCho14:0_20:4 0.04  0.01 0.04  0.01 0.700 >0.999
PtdCho14:0_22:6 0.03  0.01 0.03  0.01 0.443 >0.999
PtdCho15:0_20:4 0.04  0.01 0.04  0.01 0.804 0.131
PtdCho15:0_22:6 0.01  0.01 0.02  0.01 0.196 >0.999
PtdCho16:0_18:1 12.89  0.33 13.41  0.53 0.413 >0.999
PtdCho16:0_18:2 23.80  0.81 22.30  0.60 0.155 >0.999
PtdCho16:0_20:3 7.05  0.23 6.73  0.19 0.305 >0.999
PtdCho16:0_20:4 7.29  0.43 7.50  0.41 0.728 >0.999
PtdCho16:0_20:5 0.96  0.12 0.91  0.06 0.706 >0.999
PtdCho16:0_22:6 3.71  0.33 6.10  0.53 0.002 0.013
PtdCho17:0_18:1 0.21  0.01 0.17  0.01 0.004 >0.999
PtdCho17:0_18:2 0.60  0.03 0.43  0.01 0.001 >0.999
PtdCho17:0_20:3 0.10  0.0 0.09  0.01 0.109 >0.230
PtdCho17:0_20:4 0.22  0.02 0.20  0.02 0.558 >0.999
PtdCho17:0_22:6 0.08  0.01 0.05  0.01 0.071 0.963
PtdCho18:0_16:0 0.11  0.01 0.09  0.01 0.153 >0.999
PtdCho18:0_18:1 1.54  0.12 1.55  0.12 0.990 >0.999
PtdCho18:0_18:2 12.65  0.56 11.75  0.56 0.275 >0.999
PtdCho18:0_20:1 0.02  0.01 0.02  0.01 0.236 >0.999
PtdCho18:0_20:2 0.14  0.01 0.13  0.01 0.383 0.969
PtdCho18:0_20:3 1.14  0.13 1.29  0.19 0.511 0.927
PtdCho18:0_20:4 4.19  0.28 4.51  0.22 0.374 0.832
PtdCho18:0_20:5 0.66  0.06 0.70  0.04 0.634 0.996
PtdCho18:0_22:4 0.09  0.01 0.10  0.01 0.435 >0.999
PtdCho18:0_22:5 0.38  0.03 0.39  0.03 0.100 0.826
PtdCho18:0_22:6 1.07  0.09 1.12  0.09 0.728 >0.999
PtdCho18:1_18:2 7.19  0.23 6.84  0.19 0.254 >0.999
PtdCho18:1_20:4 1.58  0.08 1.43  0.06 0.179 >0.999
PtdCho18:1_22:6 0.25  0.02 0.17  0.01 0.007 >0.999
PtdCho18:2_18:2 7.47  0.44 7.65  0.42 0.759 >0.999
PtdCho19:0_18:2 0.06  0.01 0.05  0.01 0.012 >0.999
PtdCho20:0_16:0 0.01  0.01 0.01  0.01 0.818 >0.999
PtdCho20:4_14:1 0.01  0.01 0.01  0.01 0.908 >0.999
Total 95.60  0.22 95.86  0.21 0.401 >0.999
Values are mean  SEM (n = 10 per sex) proportions of individual molecular species in total plasma PtdCho. Comparisons of means between
sexes were by Student’s unpaired t-test after adjustment for multiple testing using the Holm-Šídák method. Molecular species are ranked by
increasing number of carbons and degree of unsaturation of the putative sn-1 fatty acid.
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PtdSer20:2_20:4 (Table 5). There were no significant dif-
ferences in the proportions of these molecular species
between sexes.
Fourteen PtdIns molecular species were identified in
men and women (Table 5). The molecular species profile
of plasma PtdIns for all participants is shown in Fig. 3. The
Table 2 Plasma phosphatidylcholine sn-1 alkyl, sn-2 ester-linked molecular species composition in men and women
Proportion of total PtdCho molecular species (%) t-Test
Molecular species Men Women p-value
PtdCho O-16:0_18:2 0.27  0.03 0.25  0.03 0.719
PtdCho O-16:0_20:4 0.48  0.05 0.52  0.04 0.432
PtdCho O-16:1_16:0 0.09  0.01 0.09  0.01 0.829
PtdCho O-16:1_18:0 0.25  0.02 0.22  0.02 0.296
PtdCho O-16:1_18:1 0.13  0.01 0.13  0.02 0.990
PtdCho O-16:1_20:5 0.02  0.00 0.02  0.01 0.871
PtdCho O-16:1_22:6 0.04  0.01 0.04  0.01 0.839
PtdCho O-16:1_18:2 0.37  0.03 0.30  0.02 0.071
PtdCho O-16:1_20:4 0.37  0.04 0.34  0.03 0.563
PtdCho O-18:0_18:2 0.11  0.01 0.09  0.01 0.248
PtdCho O-18:0_20:3 0.02  0.00 0.02  0.00 0.681
PtdCho O-18:0_20:4 0.20  0.02 0.21  0.02 0.828
PtdCho O-18:0_22:6 0.04  0.00 0.04  0.01 0.921
PtdCho O-18:1_18:2 0.17  0.01 0.15  0.02 0.421
PtdCho O-18:1_18:2 0.08  0.02 0.07  0.02 0.888
PtdCho O-18:1_20:4 0.64  0.04 0.59  0.04 0.389
PtdCho O-18:1_20:5 0.07  0.01 0.07  0.01 0.969
PtdCho O-18:2_20:4 0.22  0.02 0.19  0.01 0.196
PtdCho O-20:0_20:4 0.04  0.01 0.04  0.00 0.967
PtdCho O-20:1_20:4 0.10  0.01 0.09  0.01 0.424
Total 3.72  0.26 3.48  0.23 0.500
Values are mean  SEM (n = 10 per sex) proportions of individual molecular species in total plasma PtdCho. Comparisons of means between
sexes were by Student’s unpaired t-test with adjustment for multiple testing using the Holm-Šídák method (all adjusted p-values were nonsignifi-






















































































































































































































































































































































Fig 1 Plasma phosphatidylcholine molecular species composition. Values are proportions in descending order of individual molecular species for
n = 20 participants (men plus women, n = 10 per sex). Data points represent individual participants. Bar = mean (range). O,sn-1 alkyl,sn-2 ester
species; P,sn-1 alkenyl,sn-2 ester species
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major PtdIns molecular species in men and women was
PtdIns18:0_20:4, which alone accounted for over 42% of
total PtdIns molecular species in both sexes. There were no
significant differences in the proportions of PtdIns molecu-
lar species between sexes (Table 5).
Discussion
As described previously, the present findings show that the
plasma phospholipid pool is composed of a complex mix-
ture of phospholipid classes and molecular species (Burla
et al., 2018; Quehenberger et al., 2010), although the total
number of molecular species detected in each phospholipid
class differed to some extent from those reported here. It is
possible that this may reflect the participants in the earlier
study, who were of undisclosed sex, geographical differ-
ences in habitual diet, and being older (40–50 years old)
than those in the current study.
Each phospholipid class was composed of a relatively
small number of molecular species that accounted for the
majority of each phospholipid class and a larger number of
molecular species that individually accounted for less than
1% of total species. As described previously (Inoue
et al., 2017), each phospholipid class had a distinct
molecular species profile that differed in the diversity of the
type and combinations of fatty acids, the presence of sn-1
ether-linked fatty acids and the number of molecular species
(Kawanishi et al., 2018). For example, PtdCho and PtdEtn
contained sn-1 alkyl species, while PtdEtn, but not PtdCho,
contained sn-1 alkenyl species. Ether-linked fatty acids were
absent from PtdSer and PtdIns. The PtdCho molecular species
composition reported here is in agreement with the partial
analysis reported previously, for example PtdCho16:0/18:2,
PtdCho16:0/18:1, and PtdCho18:0/18:2 were the most abun-
dant PtdCho molecular species in pregnant women (Postle
et al., 1995). However, there are marked differences in
PtdCho molecular species composition between the current
study and Quehenberger et al., 2010. For example, the three
most abundant PtdCho species in the present study were
PtdCho16:0_18:2, PtdCho16:1_18:1, and PtdCho18:0_18:2,
while the three most abundant PtdCho species in
Quehenberger et al., 2010 were PtdCho(38:4), PtdCho(36:2),
and PtdCho(34:2) which we suggest for comparison were
PtdCho18:0_20:4, PtdCho18:1_18:1 or PtdCho18:0_18:2,
and PtdCho16:0_18:2 or 16:1_18:1, respectively. The PtdEtn
and PtdIns molecular species profiles resembled those
reported previously (Gardner et al., 2019; Kawanishi
et al., 2018; Quehenberger et al., 2010). However, these stud-
ies only reported the total number of carbons and level of
unsaturation of each molecular species instead of individual
Table 3 Plasma phosphatidylethanolamine sn-1, 2 ester-linked molecular species composition in men and women
Proportion of total PtdEtn molecular species (%) t-Test
Molecular species Men Women p
PtdEtn16:0_18:1 0.63  0.09 0.84  0.12 0.162
PtdEtn16:0_18:2 0.99  0.20 0.99  0.07 0.984
PtdEtn16:0_20:4 1.17  0.19 1.43  0.18 0.319
PtdEtn16:0_22:6 1.81  0.34 1.82  0.35 0.988
PtdEtn18:0_18:1 0.75  0.11 0.92  0.10 0.274
PtdEtn18:0_18:2 3.38  0.61 3.33  0.32 0.948
PtdEtn18:0_20:3 0.31  0.06 0.37  0.05 0.446
PtdEtn18:0_20:4 4.29  0.62 5.03  0.84 0.491
PtdEtn18:0_20:5 0.23  0.04 0.30  0.03 0.187
PtdEtn18:0_22:4 0.05  0.01 0.12  0.03 0.076
PtdEtn18:0_22:5 0.13  0.02 0.16  0.02 0.296
PtdEtn18:0_22:6 0.94  0.18 1.17  0.18 0.373
PtdEtn18:1_18:2 0.91  0.17 0.78  0.07 0.483
PtdEtn18:1_20:4 0.77  0.11 0.72  0.08 0.763
PtdEtn18:1_22:6 0.18  0.03 0.16  0.03 0.715
Total 16.54  2.37 18.50  1.86 0.601
Values are mean  SEM (n = 10 per sex) proportions of individual molecular species in total plasma PtdEtn (sn-1 fatty acid / sn-2 fatty acid).
Comparisons of means between sexes were by Student’s unpaired t-test with adjustment for multiple testing using the Holm-Šídák method (all
adjusted P values were nonsignificant and are not shown). Molecular species are ranked by increasing number of carbons and degree of
unsaturation of the putative sn-1 fatty acid.
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fatty acid combinations thus preventing direct comparison
with the present data (Gardner et al., 2019; Kawanishi
et al., 2018). Quehenberger et al. (2010) reported 20 PtdSer
molecular species compared to three PtdSer molecular species
in the present study. However, PtdSer (40:6), which we sug-
gest may have been PtdSer20:2_20:4 or PtdSer18:0_22:6,
was the predominant species in both studies. Overall, there is
broad agreement between studies about the molecular species
compositions of plasma phospholipids and their complexity.
However, differences between study designs, including selec-
tion of participants and analytical methods, and reporting of
molecular species in terms of numbers of total fatty acid
Table 4 Plasma sn-1 alkyl or sn-1 alkenyl phosphatidylethanolamine molecular species composition in men and women
Proportion of total PtdEtn molecular species (%) t-Test
Molecular species Men Women p-Value Adjusted p-value
Alkyl molecular species
PtdEtn O-16:1_18:1 0.72  0.09 0.92  0.08 0.118 0.745
PtdEtn O-16:1_18:2 1.27  0.14 1.50  0.17 0.315 0.923
PtdEtn O-16:1_20:4 3.22  0.43 5.47  0.46 0.002 0.035
PtdEtn O-16:1_20:5 0.25  0.04 0.35  0.08 0.279 0.566
PtdEtn O-16:1_22:6 2.01  0.28 2.60  0.23 0.126 0.747
PtdEtn O-18:0_20:4 0.40  0.05 0.55  0.04 0.035 0.451
PtdEtn O-18:1_18:1 0.75  0.11 0.81  0.06 0.643 0.994
PtdEtn O-18:1_18:2 3.29  0.41 3.17  0.31 0.834 0.993
PtdEtn O-18:1_20:3 0.98  0.14 1.30  0.04 0.041 0.515
PtdEtn O-18:1_20:4 5.95  0.90 7.68  0.49 0.111 0.739
PtdEtn O-18:1_20:5 0.58  0.10 0.83  0.07 0.056 0.565
PtdEtn O-18:1_22:4 0.07  0.01 0.31  0.10 0.041 0.432
PtdEtn O-18:1_22:5 1.01  0.12 1.28  0.05 0.065 0.566
PtdEtn O-18:1_22:6 2.31  0.35 2.49  0.26 0.686 0.994
PtdEtn O-18:2_18:2 1.54  0.15 1.80  0.17 0.275 0.924
PtdEtn O-18:2_20:4 4.01  0.36 5.48  0.41 0.014 0.025
PtdEtn O-18:2_20:5 0.67  0.05 0.80  0.05 0.079 0.657
PtdEtn O-18:2_22:6 1.19  0.08 1.41  0.12 0.161 0.788
PtdEtn O-20:1_18:2 0.30  0.03 0.30  0.04 0.966 0.994
PtdEtn O-20:1_20:4 0.23  0.03 0.36  0.06 0.055 0.992
PtdEtn O-20:1_22:6 0.09  0.02 0.10  0.01 0.745 0.997
Total 30.83  2.99 39.51  1.32 0.021 0.991
Alkenyl molecular species
PtdEtn P-16:0_18:1 1.06  0.17 0.63  0.08 0.041 >0.999
PtdEtn P-16:0_18:2 2.73  0.30 1.92  0.21 0.040 >0.999
PtdEtn P-16:0_20:4 8.28  0.73 8.20  0.51 0.931 >0.999
PtdEtn P-16:0_22:6 4.61  0.36 3.88  0.25 0.114 >0.999
PtdEtn P-16:0_22:6 1.17  0.21 1.09  0.24 0.816 >0.999
PtdEtn P-18:0_18:1 0.95  0.17 0.60  0.08 0.098 >0.999
PtdEtn P-18:0_18:2 4.05  0.48 2.67  0.32 0.029 >0.999
PtdEtn P-18:0_20:4 9.70  1.28 7.73  0.81 0.214 >0.999
PtdEtn P-18:0_20:5 0.77  0.07 0.57  0.07 0.071 >0.999
PtdEtn P-18:0_22:6 3.41  0.48 2.34  0.30 0.077 >0.999
PtdEtn P-18:1_18:2 2.81  0.26 2.05  0.18 0.028 >0.999
PtdEtn P-18:1_20:4 10.11  0.78 8.56  0.39 0.100 >0.999
Total 52.63  4.29 42.34  1.11 0.042 >0.999
Values are mean  SEM (n = 10 per sex) proportions of individual molecular species in total plasma PtdEtn (sn-1 fatty acid / sn-2 fatty acid).
Comparisons of means between sexes were by Student’s unpaired t-test with adjustment for multiple testing using the Holm-Šídák method.
Molecular species are ranked by increasing number of carbons and degree of unsaturation of the sn-1 fatty acid.
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carbons and double bonds which suggest alternative combina-
tions of fatty acids for each species, may account, at least in
part, for inconsistencies in findings between reports.
The proportions of 20:4n-6 and 22:6n-3 are typically
20% higher in total plasma lipids and phospholipids from
women compared to men (Lohner et al., 2013). Such sex
differences in 20:4n-6 and 22:6n-3 concentrations were
associated with differences in the concentrations of individ-
ual PtdCho and PtdEtn molecular species. In particular,
higher 22:6n-3 concentration in women than men was due
entirely to a greater proportion of PtdCho16:0_22:6. The
proportion of this species was approximately 64% greater
in women than in men. The proportions of other PtdCho
species that contained 22:6n-3 did not differ between sexes.
The sum of all PtdCho molecular species that contained
22:6n-3 showed that the proportion of this fatty acid was
significantly greater in women (7.6  0.6 mol%) than in
men (6.2  0.5 mol%; adjusted P = 0.005). The magnitude
of the difference between sexes for total PtdCho 22:6n-3
was lower (22.3%) than for PtdCho16:0_22:6 and is similar
to that estimated based on analysis of studies that measured
total plasma or total phospholipids by Lohner et al. (2013).
Thus, it is plausible that PtdCho16:0_22:6 alone may
account for the difference in the concentration or propor-
tion of 22:6n-3 between sexes, but that the magnitude of
this difference is reduced by the presence in blood of other
22:6n-6 -containing molecular species that do not exhibit
sexual dimorphism.
One previous study investigated the phospholipid com-
position of young and older men and women (Ishikawa
et al., 2014). The findings showed relatively few differ-
ences in plasma phospholipid composition between sexes
in the young participant group compared to the present
study. The primary differences between sexes were higher
proportions of individual sphingomyelin molecular species
in young women. The proportions of a greater number of
phospholipid molecular species differed between sexes in
the older participant group (Ishikawa et al., 2014). The only
finding that agreed with the present study was that the pro-
portion of PtdCho18:1_22:6 was greater in men than
women. The reason for the differences in findings between
these studies is not clear, although differences in methodol-
ogies and in the ethnicity of the participants may be
important.
The concentration of plasma PtdCho16:0/22:6 has been
shown to increase significantly during pregnancy in women
(Postle et al., 1995) and rodents (Burdge et al., 1993;
Childs et al., 2012). In rats, conversion of PtdCho16:0/22:6
to 18:0/22:6 by acyl remodeling decreased with increasing
gestational age indicating that this process is regulated by
sex hormones. One study has reported that the flux through


























































































































































































































































































































Fig 2 Plasma phosphatidylethanolamine molecular species composition of plasma. Values are proportions in descending order of individual
molecular species for n = 20 participants (men plus women, n = 10 per sex). Data points represent individual participants. Bar = mean (range).
O,sn-1 alkyl,sn-2 ester species; P,sn-1 alkenyl,sn-2 ester species
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pregnant rats (Chalil et al., 2018), although others have not
found this (Burdge et al., 1994). There was no significant
difference between sexes in the proportion of
PtdEtn16:0_22:6 in the present study. This suggests that
unlike rats (Burdge et al., 1994), sex hormones do not
appear to alter the composition of the DAG pool destined
Table 5 Plasma phosphatidylserine and phosphatidylinositol molecular species compositions in men and women
Molecular species Men Women t-Test
Proportion of total PtdSer molecular species (%) p
PtdSer18:0_18:1 9.53  2.16 21.52  6.56 0.111
PtdSer18:0_20:4 12.74  3.16 13.09  3.35 0.940
PtdSer20:2_20:4 77.73  4.32 65.39  7.85 0.190
Proportion of total PtdIns molecular species (%)
PtdIns16:0_16:1 0.57  0.05 0.60  0.12 0.227
PtdIns16:0_18:1 4.51  0.51 5.48  0.60 0.238
PtdIns16:0_18:2 3.36  0.17 3.57  0.28 0.540
PtdIns16:0_20:3 1.07  0.06 1.08  0.06 0.918
PtdIns16:0_20:4 7.24  0.68 7.08  0.53 0.859
PtdIns16:0_20:4 3.79  0.24 4.33  0.34 0.208
PtdIns18:0_18:1 6.37  0.76 8.26  1.01 0.154
PtdIns18:0_18:2 13.55  1.04 12.67  0.75 0.503
PtdIns18:0_20:3 7.00  0.67 6.77  0.38 0.778
PtdIns18:0_20:4 45.24  1.60 42.91  1.98 0.372
PtdIns18:0_22:5 0.93  0.08 0.88  0.06 0.655
PtdIns18:0_22:6 1.78  0.26 2.09  0.19 0.342
PtdIns18:1_18:2 2.64  0.18 2.27  0.08 0.089
PtdIns18:1_20:4 2.26  0.12 2.00  0.11 0.141
Values are mean  SEM (n = 10 per sex) proportions of individual molecular species (sn-1 fatty acid / sn-2 fatty acid) in each lipid class. Com-
parisons of means between sexes were by Student’s unpaired t-test with adjustment for multiple testing using the Holm-Šídák method (all
adjusted p-values were nonsignificant and are not shown). Molecular species are ranked by increasing number of carbons and degree of












































































































Fig 3 Plasma phosphatidylinositol molecular species composition. Values are proportions in descending order of individual molecular species
for n = 20 participants (men plus women, n = 10 per sex). Data points represent individual participants. Bar = mean (range). O,sn-1 alkyl,sn-2
ester species; P,sn-1 alkenyl,sn-2 ester species
Lipids
Lipids (2020)
for incorporation into PtdEtn in humans and that increased
N-methylation of PtdEtn16:0_22:6 is unlikely to account
for the greater proportion of PtdCho16:0_22:6 in women
than in men. Hepatic acyl remodeling of newly synthesized
PtdCho has also been shown to be important in humans
(Pynn et al., 2011). Flux through the Lands pathway is
reduced in pregnant compared to nonpregnant rats (Burdge
et al., 1994). This suggests that one possible explanation
for a higher proportion of PtdCho16:0_22:6 in women than
in men, is lower hepatic activity of the Lands cycle in
women. Moreover, LPAT activity, which confers specific-
ity on acyl-remodeling (Wang and Tontonoz, 2019), may
be a locus of metabolic regulation by sex hormones. If so,
greater capacity for PUFA biosynthesis in young women
compared to men (Burdge et al., 2002; Burdge and
Wootton, 2002) appears to be coordinated with PtdCho
biosynthesis by female sex hormones.
A systematic review of 51 studies found that the concen-
tration of 20:4n-6 was higher in plasma phospholipids from
women than men (Lohner et al., 2013). The present find-
ings show that the proportions of PtdEtn O-16:1_20:4,
PtdEtn O-18:2_20:4, but not of other 20:4n-6-containing
PtdEtn species, were significantly greater in women than
men. This may explain why previous studies that analyzed
either plasma total lipids or total phospholipids found a sex
difference in 20:4n-6 concentration (Lohner et al., 2013),
but this was not detected when the fatty acid composition
of purified plasma PtdCho was analyzed (Bakewell
et al., 2006). Ether-linked PtdEtn molecular species are
involved in stabilizing the structures of cell membranes
(Dean and Lodhi, 2018), although it is not known if they
also stabilize the phospholipid monolayer of lipoproteins.
Ether-linked PtdSer species have been suggested to act as
antioxidants (Meikle et al., 2011). If so, association of
20:4n-6 with ether-linked PtdEtn species may reduce free
radical-mediated oxidation. The greater overall proportion
of sn-1 alkyl-linked PtdEtn species in women compared to
men may confer a higher level of antioxidant protection in
the presence of a greater potential for oxidation due to
increased amounts of 20:4n-6 and 22:6n-3. Synthesis of
ether lipids in mammals involves a multi-step pathway that
is incompletely understood (Watschinger and
Werner, 2013). To our knowledge, sexual dimorphism in
the activity of this pathway has not been reported
previously.
PtdIns has been shown to be associated with a VLDL/
LDL fraction which suggests that it is specific component
of at least some lipoproteins although the molecular species
composition was not reported (Sun et al., 2019). It is also
possible that plasma PtdIns may reflect contamination of
plasma with cell debris. One study reported 14 PtdIns
molecular species in human platelets, of which the major
species were 38:4 > 32:0 > 38:3 (Mujalli et al., 2018)
which can be deduced tentatively to be PtdIns18:0_20:4,
PtdIns16:0_16:0, or PtdIns18:0_14:0 and PtdIns18:0_20:3,
respectively. Although PtdIns18:0_20:4 is the most abun-
dant species in most cell membranes (Holub, 1986),
PtdIns18:0_18:2 and PtdIns16:0_20:4 were the second and
third most abundant plasma PtdIns molecular species in the
present study. Furthermore, no disaturated PtdIns species
were detected in plasma. Thus, although contamination of
plasma with membrane PtdIns from platelets or cells cannot
be completely excluded, we suggest that any such contami-
nation would be a minor artifact in the analysis and that
plasma PtdIns is probably associated primarily with
lipoproteins.
PtdSer has been detected in microparticles in blood that
have been implicated in hypercoagulation in diabetic kid-
ney disease (Yu et al., 2018), cancer (Lea et al., 2017; Liu
et al., 2019; Zhao et al., 2016), and inflammation (Zhao
et al., 2016). Whether PtdSer is also an integral component
of lipoproteins in humans is not known. PtdSer was not
detected in the only previous study which attempted to
measured PtdSer in VLDL (Sun et al., 2019) and the pre-
sent data show that PtdSer accounted for less than 0.02% of
plasma total phospholipids. The role of PtdSer as a focus
for coagulation may preclude its incorporation into the sur-
face monolayer of lipoproteins.
Although the diets of the participants were not controlled,
the rank order of molecular species within each phospholipid
class was broadly consistent between individuals thus produc-
ing a characteristic molecular species profile for each phos-
pholipid class. Plasma phospholipid molecular species
composition is regulated by the specificity of the hepatic syn-
thesis of each phospholipid class and differential incorporation
of each class into nascent lipoproteins (Pynn et al., 2011). For
example, PtdCho is the major phospholipid class associated
with liver-derived lipoproteins which form the phospholipid
monolayer (Nelson & Freeman 1960), while nascent VLDL
particles are enriched in PtdEtn which is progressively
removed between hepatocyte Golgi apparatus and secretion
into blood (Hamilton and Fielding, 1989). The diversity of
molecular species between phospholipid classes, while
retaining characteristic profiles between individuals, is consis-
tent with the specificity of hepatic phospholipid biosynthesis
being a primary determinant of plasma phospholipid molecu-
lar species composition (Burdge et al., 1994; Pynn
et al., 2011). Demonstration that the proportions of individual
plasma molecular species can be influenced by sex, aging
(Kawanishi et al., 2018), pregnancy (Postle et al., 1995), and
obesity (Donovan et al., 2013) suggests that endocrine factors
are an important influence on hepatic phospholipid and lipo-
protein metabolism.
The main limitation of this observational study is that it
only allowed speculation about the underlying processes
instead of providing direct mechanistic insights, for
Lipids
Lipids (2020)
example based on tracer technologies. Such interpretations
were based on measurements of total plasma, while it
would have been preferable to have analyzed isolated
VLDL particles as a more direct representation of hepatic
phospholipid metabolism. It was not possible to test
directly the effects of differences in phospholipid composi-
tion on VLDL structure and function. Additional limita-
tions of this exploratory study include the relatively small
sample size, and limited range of ages and ethnicities which
constrain the extent to which the findings can be extrapo-
lated to the wider population. Nevertheless, the findings
show for the first time that plasma phospholipid composi-
tion can be influenced by sex. One future challenge will be
to test whether such sexual dimorphism in phospholipid
molecular species composition contributes to sex differ-
ences in lipoprotein metabolism and health outcomes.
It has been proposed that specific phospholipid molecular
species in cell membranes act as “pivot” species which are
resistant to hydrolysis and are required for maintaining mem-
brane structure (Dymond et al., 2013). We have suggested
that such pivot species may be present in lipoproteins and are
required to maintain the structure of the phospholipid mono-
layer and/or facilitate the activities of lipases (West
et al., 2020). Hepatic and/or plasma PtdCho16:0/22:6 concen-
tration in humans and rodents can be modified by sex hor-
mones (Burdge et al., 1994; Chalil et al., 2018; Childs
et al., 2012; Postle et al., 1995) and appears to be resistant to
postprandial hydrolysis (West et al., 2020). Thus
PtdCho16:0/22:6 may be a pivot molecular species in lipopro-
teins. PtdEtn regulates the curvature of in the inner mitochon-
drial membranes and is involved in points of membrane
contact, by disrupting the PtdCho bilayer due to the inverted
hexagonal packing of PtdEtn molecules (Daum and
Vance, 1997). PtdIns has also been shown to promote mem-
brane curvature (Mulet et al., 2008), although whether PtdEtn
and PtdIns are involved in regulating membrane shape in lipo-
proteins is not known.
One possible explanation for the large number of plasma
phospholipid molecular species is that the overall effect on
the biophysical properties of the phospholipid monolayer
produces an optimal environment for lipoprotein function
including the activities of integral proteins. If so, sex differ-
ences in plasma phospholipid classes and molecular species
compositions may modify lipoprotein function in a manner
that contributes to different patterns of health and disease
between men and women.
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